TSX/NVS (TSX/NVS)

Toronto Stock Exchange: TSX/NVS · CAD

CA$30.8

-0.44 (-1.4%)· Recorded snapshot

Market cap	406.4B
Revenue (ttm)	81.4B
Net income (ttm)	14.2B
EPS (ttm)	CA$0.74
P/E (trailing)	41.7x
P/E (forward)	16.1x
Dividend	CA$0.87 (2.83%)
Volume	200

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 81.4B
Net income (ttm): 14.2B
EPS (ttm): CA$0.74
P/E (trailing): 41.7x
P/E (forward): 16.1x
Market cap: 406.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.1

P25 n/aP50 n/aP75 n/a

Trailing P/E41.7

P25 n/aP50 n/aP75 n/a

ROE24.3

P25 n/aP50 n/aP75 n/a

ROIC19.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All TSX/NVS indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

USD

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CAD
Country	Switzerland
Country code	CA
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	CAD 462.6B
Exchange	Toronto Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	CA66989X1033
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Market cap	CAD 406.4B
Next earnings date	2027-02-03
Price	CAD 30.76
Price currency	CAD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	tsx/NVS
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	2.4%
EV/Earnings	32.9x
EV/EBIT	17x
EV/EBITDA	13.61x
EV/FCF	21.08x
EV/Sales	5.78x
FCF / EV yield	4.74%
FCF yield	5.39%
Forward P/E	16.08x
Graham number	9.89372
Graham upside	-68.29%
Lynch fair value	CAD 5.39
Lynch upside	-82.73%
P/(FCF - SBC) ratio	20x
P/(OCF - SBC) ratio	17.94x
P/B ratio	7.73x
P/E ratio	41.66x
P/FCF ratio	18.55x
P/OCF ratio	16.76x
P/S ratio	5.06x
Price/EBITDA ratio	12.07x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.94%
Effective tax rate	20.8%
FCF margin	27.6%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	CAD 189,200
Profitable quarters	106
Profitable years	28
Revenue per employee	CAD 1.1M
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.31%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.4%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	1.26%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CAD -2.4B
Depreciation and amortization	CAD 6.4B
EBIT	CAD 27.7B
EBITDA	CAD 34.2B
EPS	CAD 0.74
Financing cash flow	CAD 1.1B
Free cash flow	CAD 22.2B
Free cash flow minus SBC	CAD 20.6B
Gross profit	CAD 61.2B
Income taxes	CAD 3.7B
Investing cash flow	CAD -26.5B
Net borrowing	CAD 22.7B
Net cash flow	CAD -973.9M
Net income	CAD 14.2B
Operating cash flow minus SBC	CAD 23B
Operating income	CAD 27.7B
Revenue	CAD 81.4B
Stock-based compensation	CAD 1.6B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.56
Book value per share	CAD 27.98
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	CAD 38.2B
Interest coverage	12.36
Long-term assets	CAD 125.9B
Long-term liabilities	CAD 67.3B
Net cash (debt)	CAD -56B
Net cash / market cap	-13.58%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	CAD 17.2B
Shareholders' equity	CAD 53.3B
Tangible book value	CAD -42.3B
Tangible book value per share	CAD -22.38
Total assets	CAD 166.3B
Total cash	CAD 12.6B
Total debt	CAD 68.6B
Total liabilities	CAD 113B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	CAD 40.4B
Current liabilities	CAD 45.7B
Current ratio	0.88
Inventory turnover	2.27
Net working capital	CAD -3.9B
Quick ratio	0.58
Working capital	CAD -5.4B
Working capital turnover	-21.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.76%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-03-19
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	CAD 0.87
Dividend yield	2.83%
Ex-dividend date	2026-03-11
Last dividend	CAD 0.87
Payout ratio	90.4%
Shareholder yield	5.56%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CAD 28.80
1D price change	-1.41%
1M price change	6.99%
1M total return	6.99%
1W price change	2.53%
1W total return	2.53%
1Y price change	25.81%
1Y return CAGR	29.73%
1Y total return	29.71%
20-day SMA	CAD 29.10
200-day SMA	CAD 27.85
3M price change	0.49%
3M total return	0.49%
50-day SMA	CAD 29.14
50-day SMA vs 200-day SMA	50over200
52-week high	CAD 31.43
52-week high date	2026-09-03
52-week low	CAD 23.10
52-week low date	2025-10-28
6M price change	14.1%
6M total return	14.1%
All-time high	CAD 31.43
All-time high date	2026-09-03
All-time low	CAD 20.11
All-time low date	2025-04-10
Average true range (ATR)	CAD 0.59
Average volume	639.3
Change from 52-week high	-2.13%
Change from 52-week low	33.16%
Change from all-time high	-2.13%
Change from all-time low	52.96%
Change from open	-0.71%
Day's gap	-0.71%
Dollar volume	CAD 6,152
High price	CAD 30.98
Low price	CAD 30.76
Monthly RSI	65.78
Open price	CAD 30.98
Position in 52-week range	0%
Previous close	CAD 31.20
Price vs 150-day SMA	6.79%
Price vs 20-day SMA	5.7%
Price vs 200-day SMA	10.46%
Price vs 50-day SMA	5.56%
Relative volume	0.31
RSI	60.53
Sharpe ratio	1
Sortino ratio	1.46
Volume	200
Weekly RSI	59.82
YTD price change	17.67%
YTD total return	21.32%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.9B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.76%
Shares held by insiders	0.11%
Shares held by institutions	36.29%

Deeper analysis on TSX/NVS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this TSX/NVS report

Is a complete TSX/NVS research report available?

No complete published report is available for tsx/NVS (TSX/NVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSX/NVS (TSX/NVS)

Price

Financial snapshot

Fair-value bridge

Latest news · TSX/NVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSX/NVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TSX/NVS

Frequently asked questions